Avalyn Pharma (AVLN) Stock Chart & Stock Price History $28.84 +0.43 (+1.51%) As of 05/22/2026 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock Avalyn Pharma Stock Price Performance The Avalyn Pharma (AVLN) stock chart highlights key performance trends across multiple timeframes. As of the latest close, Avalyn Pharma traded at $28.84 with a market cap of $1.21 billion and volume of 321,471 shares. Receive AVLN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avalyn Pharma and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+2.60% AVLN Stock Chart for Sunday, May, 24, 2026 AVLN Chart by TradingView Avalyn Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/22/2026$28.41$28.84+1.51%$29.67$26.68321,471 shs$1.21 billion05/21/2026$28.03$28.41+1.36%$28.61$26.68238,433 shs$1.19 billion05/20/2026$28.11$28.03-0.28%$28.50$26.01181,017 shs$1.17 billion05/19/2026$26.63$28.11+5.56%$28.61$26.00126,127 shs$1.18 billion05/18/2026$29.84$26.63-10.76%$29.80$25.21429,962 shs$1.11 billion05/15/2026$30.62$29.84-2.55%$31.00$28.01204,706 shs$1.25 billion05/14/2026$30.83$30.62-0.68%$31.34$28.80178,225 shs$1.28 billion05/13/2026$29.90$30.83+3.11%$32.22$28.36402,327 shs$0.0005/12/2026$29.57$29.90+1.12%$31.02$29.25308,642 shs$0.0005/11/2026$27.33$29.57+8.20%$30.43$27.27284,091 shs$0.00 Get the Latest News and Ratings for AVLN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avalyn Pharma and its competitors with MarketBeat's FREE daily newsletter. 05/08/2026$26.93$27.33+1.49%$29.00$26.64290,424 shs$0.0005/07/2026$27.71$26.93-2.81%$27.50$25.39664,374 shs$0.0005/06/2026$27.43$27.71+1.02%$27.74$25.05662,850 shs$0.0005/05/2026N/A$27.43$29.64$25.44467,963 shs$0.0004/30/2026$29.49$29.84+1.19%$27.50N/A830,048 shs$0.0004/29/2026N/A$29.49$26.00N/A6.51 million shs$0.00 Related Companies Dianthus Therapeutics Stock Price Chart Anbio Biotechnology Stock Price Chart Indivior Stock Price Chart MANE Stock Price Chart NewAmsterdam Pharma Stock Price Chart Travere Therapeutics Stock Price Chart Kiniksa Pharmaceuticals International Stock Price Chart Amneal Pharmaceuticals Stock Price Chart Crinetics Pharmaceuticals Stock Price Chart Catalyst Pharmaceuticals Stock Price Chart Receive AVLN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avalyn Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVLN) was last updated on 5/24/2026 by MarketBeat.com Staff. From Our PartnersA 25,000% opportunityAngel investor Jason Calacanis - who made a fortune on an early Uber stake - says Elon Musk's latest project c...The Oxford Club | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredDistracted Americans set to miss out on quadrillionsTechnology expert and Washington D.C. insider Jeff Brown - who identified Bitcoin, Tesla, and Nvidia early - s...Brownstone Research | SponsoredMusk’s Next $4 Trillion Takeover Target – It’s Stranger than you ThinkTech analyst Ian King - who called an early Tesla trade that returned up to 1,000% in just over a year - says ...Banyan Hill Publishing | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | SponsoredYour computer is about to become a museum pieceFor 67 years, chip-making meant slicing a single silicon wafer into hundreds of pieces. Three companies just a...Eagle Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalyn Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avalyn Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
